| Filed | As-Of/On | Form | Fullname | Fund Class | Shares | Activity | Shares Change | Shares Pct. Change | Hypothetical Old Value | Hypothetical New Value | Hypothetical Value Chg. | Hypotheticals Return |
Hypotheticals Results |
Director |
Other |
Ten Pct |
Officer |
Officer Title |
News Article |
History |
|---|
| 2009-11-17 | 2009-09-30 | 13F-HR/A | Amvescap Plc | Institution | 3,468 | Added More | 941 | 37.23 % | $23,062 | $22,091 | $-971 | -4.21 % | $-263 | | | | | | News Article | History of Amvescap Plc Ownership Of Halozyme Therapeutics Inc |
| 2009-11-17 | 2009-09-30 | 13F-HR/A | Credit Suisse First Boston | Institution | | Sold All | -70,240 | -100 % | | | | -4.21 % | $19,667 | | | | | | News Article | History of Credit Suisse First Boston Ownership Of Halozyme Therapeutics Inc |
| 2009-11-17 | 2009-09-30 | 13F-HR | Wells Fargo And Co | Institution | 16,600 | Sold Some | -5,500 | -24.88 % | $110,390 | $105,742 | $-4,648 | -4.21 % | $1,540 | | | | | | News Article | History of Wells Fargo And Co Ownership Of Halozyme Therapeutics Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Alyeska Investment Group Lp | No Data | | Sold All | -75,000 | -100 % | | | | -6.87 % | $35,250 | | | | | | News Article | History of Alyeska Investment Group Lp Ownership Of Halozyme Therapeutics Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | American International Group Inc | Institution | 178,175 | Added More | 127,328 | 250.41 % | $1,218,717 | $1,134,975 | $-83,742 | -6.87 % | $-59,844 | | | | | | News Article | History of American International Group Inc Ownership Of Halozyme Therapeutics Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Aqr Capital Management Llc | Institution | 24,186 | New Holding | 24,186 | 100 % | $165,432 | $154,065 | $-11,367 | -6.87 % | $-11,367 | | | | | | News Article | History of Aqr Capital Management Llc Ownership Of Halozyme Therapeutics Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Bonanza Capital Ltd | Institution | 35,714 | New Holding | 35,714 | 100 % | $244,284 | $227,498 | $-16,786 | -6.87 % | $-16,786 | | | | | | News Article | History of Bonanza Capital Ltd Ownership Of Halozyme Therapeutics Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Citadel L P | Institution | 20,316 | Added More | 62 | 0.30 % | $138,961 | $129,413 | $-9,549 | -6.87 % | $-29 | | | | | | News Article | History of Citadel L P Ownership Of Halozyme Therapeutics Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Dafna Capital Management Llc | Institution | 23,016 | Sold Some | -126,984 | -84.65 % | $157,429 | $146,612 | $-10,818 | -6.87 % | $59,682 | | | | | | News Article | History of Dafna Capital Management Llc Ownership Of Halozyme Therapeutics Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Deerfield Management Co | Institution | 2,593,567 | Sold Some | -577,809 | -18.21 % | $17,739,998 | $16,521,022 | $-1,218,976 | -6.87 % | $271,570 | | | | | | News Article | History of Deerfield Management Co Ownership Of Halozyme Therapeutics Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Driehaus Capital Management Llc | Institution | 308,976 | Added More | 160,511 | 108.11 % | $2,113,396 | $1,968,177 | $-145,219 | -6.87 % | $-75,440 | | | | | | News Article | History of Driehaus Capital Management Llc Ownership Of Halozyme Therapeutics Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Employees Retirement System Of Texas | Institution | 247,000 | Sold Some | -157,000 | -38.86 % | $1,689,480 | $1,573,390 | $-116,090 | -6.87 % | $73,790 | | | | | | News Article | History of Employees Retirement System Of Texas Ownership Of Halozyme Therapeutics Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Fmr Corp | Institution | 301,900 | No Change | 0 | 0 % | $2,064,996 | $1,923,103 | $-141,893 | -6.87 % | $0 | | | | | | News Article | History of Fmr Corp Ownership Of Halozyme Therapeutics Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Galleon Management L P | Institution | 100,000 | Added More | 65,000 | 185.71 % | $684,000 | $637,000 | $-47,000 | -6.87 % | $-30,550 | | | | | | News Article | History of Galleon Management L P Ownership Of Halozyme Therapeutics Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Ing Groep Nv | Institution | 23,560 | Added More | 4,410 | 23.02 % | $161,150 | $150,077 | $-11,073 | -6.87 % | $-2,073 | | | | | | News Article | History of Ing Groep Nv Ownership Of Halozyme Therapeutics Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Leuthold Weeden Capital Management Llc | Institution | 438,837 | Added More | 25,777 | 6.24 % | $3,001,645 | $2,795,392 | $-206,253 | -6.87 % | $-12,115 | | | | | | News Article | History of Leuthold Weeden Capital Management Llc Ownership Of Halozyme Therapeutics Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Millennium Management Llc | Institution | | Sold All | -652,457 | -100 % | | | | -6.87 % | $306,655 | | | | | | News Article | History of Millennium Management Llc Ownership Of Halozyme Therapeutics Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Moore Capital Management Lp | Institution | | Sold All | -150,000 | -100 % | | | | -6.87 % | $70,500 | | | | | | News Article | History of Moore Capital Management Lp Ownership Of Halozyme Therapeutics Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Morgan Stanley | Institution | 51,119 | Added More | 14,911 | 41.18 % | $349,654 | $325,628 | $-24,026 | -6.87 % | $-7,008 | | | | | | News Article | History of Morgan Stanley Ownership Of Halozyme Therapeutics Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Northern Trust Co Of Connecticut | Institution | | Sold All | -80,989 | -100 % | | | | -6.87 % | $38,065 | | | | | | News Article | History of Northern Trust Co Of Connecticut Ownership Of Halozyme Therapeutics Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Northern Trust Corp | Institution | 778,886 | Added More | 118,319 | 17.91 % | $5,327,580 | $4,961,504 | $-366,076 | -6.87 % | $-55,610 | | | | | | News Article | History of Northern Trust Corp Ownership Of Halozyme Therapeutics Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR/A | Oppenheimer Funds Inc | Institution | 2,400 | Added More | 500 | 26.31 % | $16,416 | $15,288 | $-1,128 | -6.87 % | $-235 | | | | | | News Article | History of Oppenheimer Funds Inc Ownership Of Halozyme Therapeutics Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Qvt Financial Lp | Institution | 3,939,844 | Sold Some | -686,507 | -14.83 % | $26,948,533 | $25,096,806 | $-1,851,727 | -6.87 % | $322,658 | | | | | | News Article | History of Qvt Financial Lp Ownership Of Halozyme Therapeutics Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Samlyn Capital Llc | Institution | 612,770 | Added More | 12,770 | 2.12 % | $4,191,347 | $3,903,345 | $-288,002 | -6.87 % | $-6,002 | | | | | | News Article | History of Samlyn Capital Llc Ownership Of Halozyme Therapeutics Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Shaw D E And Co Inc | Institution | 149,741 | Added More | 134,746 | 898.60 % | $1,024,228 | $953,850 | $-70,378 | -6.87 % | $-63,331 | | | | | | News Article | History of Shaw D E And Co Inc Ownership Of Halozyme Therapeutics Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Straus Capital Management Llc | Institution | 674,031 | Added More | 19,000 | 2.90 % | $4,610,372 | $4,293,577 | $-316,795 | -6.87 % | $-8,930 | | | | | | News Article | History of Straus Capital Management Llc Ownership Of Halozyme Therapeutics Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Tryphon Capital Advisers Inc | Institution | 40,369 | New Holding | 40,369 | 100 % | $276,124 | $257,151 | $-18,973 | -6.87 % | $-18,973 | | | | | | News Article | History of Tryphon Capital Advisers Inc Ownership Of Halozyme Therapeutics Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Ubs Global Asset Management Americas Inc | Institution | 470,279 | Sold Some | -20,800 | -4.23 % | $3,216,708 | $2,995,677 | $-221,031 | -6.87 % | $9,776 | | | | | | News Article | History of Ubs Global Asset Management Americas Inc Ownership Of Halozyme Therapeutics Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Us Bancorp De | Institution | 227,593 | Added More | 41,717 | 22.44 % | $1,556,736 | $1,449,767 | $-106,969 | -6.87 % | $-19,607 | | | | | | News Article | History of Us Bancorp De Ownership Of Halozyme Therapeutics Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Weiss Multi-Strategy Advisers Llc | Institution | 140,000 | Added More | 110,000 | 366.66 % | $957,600 | $891,800 | $-65,800 | -6.87 % | $-51,700 | | | | | | News Article | History of Weiss Multi-Strategy Advisers Llc Ownership Of Halozyme Therapeutics Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Ameriprise Financial Inc | Institution | | Sold All | -27,600 | -100 % | | | | -4.78 % | $8,832 | | | | | | News Article | History of Ameriprise Financial Inc Ownership Of Halozyme Therapeutics Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Axa | Institution | 297,681 | Sold Some | -47,275 | -13.70 % | $1,991,486 | $1,896,228 | $-95,258 | -4.78 % | $15,128 | | | | | | News Article | History of Axa Ownership Of Halozyme Therapeutics Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Barclays Plc | Institution | 49,000 | Added More | 47,819 | 4049.02 % | $327,810 | $312,130 | $-15,680 | -4.78 % | $-15,302 | | | | | | News Article | History of Barclays Plc Ownership Of Halozyme Therapeutics Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Bnp Paribas Arbitrage Sa | Institution | 24,424 | New Holding | 24,424 | 100 % | $163,397 | $155,581 | $-7,816 | -4.78 % | $-7,816 | | | | | | News Article | History of Bnp Paribas Arbitrage Sa Ownership Of Halozyme Therapeutics Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Credit Agricole S A | Institution | 50,000 | No Change | 0 | 0 % | $334,500 | $318,500 | $-16,000 | -4.78 % | $0 | | | | | | News Article | History of Credit Agricole S A Ownership Of Halozyme Therapeutics Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Dekabank Deutsche Girozentrale | No Data | 273,200 | No Change | 0 | 0 % | $1,827,708 | $1,740,284 | $-87,424 | -4.78 % | $0 | | | | | | News Article | History of Dekabank Deutsche Girozentrale Ownership Of Halozyme Therapeutics Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Diamondback Capital Management Llc | Institution | 444,700 | Added More | 286,200 | 180.56 % | $2,975,043 | $2,832,739 | $-142,304 | -4.78 % | $-91,584 | | | | | | News Article | History of Diamondback Capital Management Llc Ownership Of Halozyme Therapeutics Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Farr Miller And Washington Llc Dc | Institution | 30,000 | No Change | 0 | 0 % | $200,700 | $191,100 | $-9,600 | -4.78 % | $0 | | | | | | News Article | History of Farr Miller And Washington Llc Dc Ownership Of Halozyme Therapeutics Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Gartmore Mutual Fund Capital Trust | Institution | 380 | Sold Some | -54,120 | -99.30 % | $2,542 | $2,421 | $-122 | -4.78 % | $17,318 | | | | | | News Article | History of Gartmore Mutual Fund Capital Trust Ownership Of Halozyme Therapeutics Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Geduld E E | Institution | | Sold All | -25,000 | -100 % | | | | -4.78 % | $8,000 | | | | | | News Article | History of Geduld E E Ownership Of Halozyme Therapeutics Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Geode Capital Management Llc | Institution | 179,944 | Added More | 9,725 | 5.71 % | $1,203,825 | $1,146,243 | $-57,582 | -4.78 % | $-3,112 | | | | | | News Article | History of Geode Capital Management Llc Ownership Of Halozyme Therapeutics Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Goldman Sachs Group Inc | Institution | 94,720 | Sold Some | -113,532 | -54.51 % | $633,677 | $603,366 | $-30,310 | -4.78 % | $36,330 | | | | | | News Article | History of Goldman Sachs Group Inc Ownership Of Halozyme Therapeutics Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Henderson Group Plc | Institution | | Sold All | -500,000 | -100 % | | | | -4.78 % | $160,000 | | | | | | News Article | History of Henderson Group Plc Ownership Of Halozyme Therapeutics Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Price T Rowe Associates Inc | Institution | 25,600 | No Change | 0 | 0 % | $171,264 | $163,072 | $-8,192 | -4.78 % | $0 | | | | | | News Article | History of Price T Rowe Associates Inc Ownership Of Halozyme Therapeutics Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Rbc Dain Rauscher Inc | Institution | 13,053 | Added More | 11,053 | 552.65 % | $87,325 | $83,148 | $-4,177 | -4.78 % | $-3,537 | | | | | | News Article | History of Rbc Dain Rauscher Inc Ownership Of Halozyme Therapeutics Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Sg Americas Securities Llc | Institution | 21,628 | New Holding | 21,628 | 100 % | $144,691 | $137,770 | $-6,921 | -4.78 % | $-6,921 | | | | | | News Article | History of Sg Americas Securities Llc Ownership Of Halozyme Therapeutics Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR/A | Sun Life Financial Inc | Institution | 691,890 | No Change | 0 | 0 % | $4,628,744 | $4,407,339 | $-221,405 | -4.78 % | $0 | | | | | | News Article | History of Sun Life Financial Inc Ownership Of Halozyme Therapeutics Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Vanguard Group Inc | Institution | 3,244,668 | Added More | 112,651 | 3.59 % | $21,706,829 | $20,668,535 | $-1,038,294 | -4.78 % | $-36,048 | | | | | | News Article | History of Vanguard Group Inc Ownership Of Halozyme Therapeutics Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Allianz Global Investors Of America L P | Institution | | Sold All | -143,900 | -100 % | | | | 0.15 % | $-1,439 | | | | | | News Article | History of Allianz Global Investors Of America L P Ownership Of Halozyme Therapeutics Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Bank Of America Corp | Institution | 380,548 | Sold Some | -1,877 | -0.49 % | $2,420,285 | $2,424,091 | $3,805 | 0.15 % | $-19 | | | | | | News Article | History of Bank Of America Corp Ownership Of Halozyme Therapeutics Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Barclays Global Investors Uk Holdings Ltd | Institution | 3,252,060 | Added More | 428,062 | 15.15 % | $20,683,102 | $20,715,622 | $32,521 | 0.15 % | $4,281 | | | | | | News Article | History of Barclays Global Investors Uk Holdings Ltd Ownership Of Halozyme Therapeutics Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Bbt Capital Management Inc | Institution | 300,000 | Added More | 100,000 | 50.00 % | $1,908,000 | $1,911,000 | $3,000 | 0.15 % | $1,000 | | | | | | News Article | History of Bbt Capital Management Inc Ownership Of Halozyme Therapeutics Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Credit Suisse | Institution | 17,460 | New Holding | 17,460 | 100 % | $111,046 | $111,220 | $175 | 0.15 % | $175 | | | | | | News Article | History of Credit Suisse Ownership Of Halozyme Therapeutics Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Franklin Resources Inc | Institution | 118,200 | No Change | 0 | 0 % | $751,752 | $752,934 | $1,182 | 0.15 % | $0 | | | | | | News Article | History of Franklin Resources Inc Ownership Of Halozyme Therapeutics Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR/A | Ing Investment Management Co | Institution | 23,160 | Added More | 4,010 | 20.93 % | $147,298 | $147,529 | $232 | 0.15 % | $40 | | | | | | News Article | History of Ing Investment Management Co Ownership Of Halozyme Therapeutics Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Levin Capital Strategies L P | Institution | 232,025 | Added More | 66,392 | 40.08 % | $1,475,679 | $1,477,999 | $2,320 | 0.15 % | $664 | | | | | | News Article | History of Levin Capital Strategies L P Ownership Of Halozyme Therapeutics Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Merrill Lynch And Co Inc | Institution | 42,000 | Sold Some | -30,750 | -42.26 % | $267,120 | $267,540 | $420 | 0.15 % | $-308 | | | | | | News Article | History of Merrill Lynch And Co Inc Ownership Of Halozyme Therapeutics Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Mfc Global Investment Management Usa Ltd | Institution | 66,426 | Added More | 7,000 | 11.77 % | $422,469 | $423,134 | $664 | 0.15 % | $70 | | | | | | News Article | History of Mfc Global Investment Management Usa Ltd Ownership Of Halozyme Therapeutics Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Padco Advisors Ii Inc | Institution | 43,223 | Added More | 14,466 | 50.30 % | $274,898 | $275,331 | $432 | 0.15 % | $145 | | | | | | News Article | History of Padco Advisors Ii Inc Ownership Of Halozyme Therapeutics Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Padco Advisors Inc | Institution | 290,132 | Added More | 113,434 | 64.19 % | $1,845,240 | $1,848,141 | $2,901 | 0.15 % | $1,134 | | | | | | News Article | History of Padco Advisors Inc Ownership Of Halozyme Therapeutics Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Rs Investment Management Co Llc | Institution | 1,003,315 | New Holding | 1,003,315 | 100 % | $6,381,083 | $6,391,117 | $10,033 | 0.15 % | $10,033 | | | | | | News Article | History of Rs Investment Management Co Llc Ownership Of Halozyme Therapeutics Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Security Management Co Llc | Institution | 33,350 | No Change | 0 | 0 % | $212,106 | $212,440 | $334 | 0.15 % | $0 | | | | | | News Article | History of Security Management Co Llc Ownership Of Halozyme Therapeutics Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Susquehanna International Group Llp | Institution | 27,270 | Added More | 20,263 | 289.18 % | $173,437 | $173,710 | $273 | 0.15 % | $203 | | | | | | News Article | History of Susquehanna International Group Llp Ownership Of Halozyme Therapeutics Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Ubs Oconnor Llc | Institution | | Sold All | -140,675 | -100 % | | | | 0.15 % | $-1,407 | | | | | | News Article | History of Ubs Oconnor Llc Ownership Of Halozyme Therapeutics Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Baker Bros Advisors Llc | Institution | 1,969,512 | No Change | 0 | 0 % | $12,073,109 | $12,545,791 | $472,683 | 3.91 % | $0 | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Halozyme Therapeutics Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Citigroup Inc | Institution | | Sold All | -29,483 | -100 % | | | | 3.91 % | $-7,076 | | | | | | News Article | History of Citigroup Inc Ownership Of Halozyme Therapeutics Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Comerica Bank | Institution | 12,537 | New Holding | 12,537 | 100 % | $76,852 | $79,861 | $3,009 | 3.91 % | $3,009 | | | | | | News Article | History of Comerica Bank Ownership Of Halozyme Therapeutics Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | D L Carlson Investment Group Inc | Institution | 13,400 | No Change | 0 | 0 % | $82,142 | $85,358 | $3,216 | 3.91 % | $0 | | | | | | News Article | History of D L Carlson Investment Group Inc Ownership Of Halozyme Therapeutics Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | J P Morgan Chase And Co | Institution | 1,529,996 | Added More | 169,349 | 12.44 % | $9,378,875 | $9,746,075 | $367,199 | 3.91 % | $40,644 | | | | | | News Article | History of J P Morgan Chase And Co Ownership Of Halozyme Therapeutics Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Paradigm Capital Management Inc | Institution | 10,000 | No Change | 0 | 0 % | $61,300 | $63,700 | $2,400 | 3.91 % | $0 | | | | | | News Article | History of Paradigm Capital Management Inc Ownership Of Halozyme Therapeutics Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Royce And Associates Llc | Institution | 2,000 | New Holding | 2,000 | 100 % | $12,260 | $12,740 | $480 | 3.91 % | $480 | | | | | | News Article | History of Royce And Associates Llc Ownership Of Halozyme Therapeutics Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Tesseract Capital Llc | No Data | 900 | Added More | 733 | 438.92 % | $5,517 | $5,733 | $216 | 3.91 % | $176 | | | | | | News Article | History of Tesseract Capital Llc Ownership Of Halozyme Therapeutics Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Ubs Ag | Institution | 138,685 | Added More | 94,452 | 213.53 % | $850,139 | $883,423 | $33,284 | 3.91 % | $22,668 | | | | | | News Article | History of Ubs Ag Ownership Of Halozyme Therapeutics Inc |
| 2009-11-09 | 2009-09-30 | 13F-HR | Aberdeen Asset Management Plc | Institution | 120,800 | New Holding | 120,800 | 100 % | $755,000 | $769,496 | $14,496 | 1.92 % | $14,496 | | | | | | News Article | History of Aberdeen Asset Management Plc Ownership Of Halozyme Therapeutics Inc |
| 2009-11-09 | 2009-09-30 | 13F-HR | Federated Investors Inc | Institution | | Sold All | -203,250 | -100 % | | | | 1.92 % | $-24,390 | | | | | | News Article | History of Federated Investors Inc Ownership Of Halozyme Therapeutics Inc |
| 2009-11-09 | 2009-09-30 | 13F-HR | Lee Munder Capital Group Llc | No Data | 141,482 | No Compare | | | $884,263 | $901,240 | $16,978 | 1.92 % | | | | | | | News Article | History of Lee Munder Capital Group Llc Ownership Of Halozyme Therapeutics Inc |
| 2009-11-06 | 2009-09-30 | 13F-HR | Copper Rock Capital Partners Llc | Institution | 1,152,719 | Sold Some | -115,312 | -9.09 % | $7,043,113 | $7,342,820 | $299,707 | 4.25 % | $-29,981 | | | | | | News Article | History of Copper Rock Capital Partners Llc Ownership Of Halozyme Therapeutics Inc |
| 2009-11-06 | 2009-09-30 | 13F-HR | Metropolitan Life Insurance Co | Institution | 56,251 | No Change | 0 | 0 % | $343,694 | $358,319 | $14,625 | 4.25 % | $0 | | | | | | News Article | History of Metropolitan Life Insurance Co Ownership Of Halozyme Therapeutics Inc |
| 2009-11-06 | 2009-09-30 | 13F-HR | Schwab Charles Investment Management Inc | Institution | 100,800 | No Change | 0 | 0 % | $615,888 | $642,096 | $26,208 | 4.25 % | $0 | | | | | | News Article | History of Schwab Charles Investment Management Inc Ownership Of Halozyme Therapeutics Inc |
| 2009-11-06 | 2009-09-30 | 13F-HR | Teachers Advisors Inc | Institution | 475,914 | Added More | 46,194 | 10.74 % | $2,907,835 | $3,031,572 | $123,738 | 4.25 % | $12,010 | | | | | | News Article | History of Teachers Advisors Inc Ownership Of Halozyme Therapeutics Inc |
| 2009-11-06 | 2009-09-30 | 13F-HR | Tiaa Cref Investment Management Llc | Institution | 463,688 | Sold Some | -45,677 | -8.96 % | $2,833,134 | $2,953,693 | $120,559 | 4.25 % | $-11,876 | | | | | | News Article | History of Tiaa Cref Investment Management Llc Ownership Of Halozyme Therapeutics Inc |
| 2009-11-05 | 2009-09-30 | 13F-HR | Apex Capital Llc | Institution | 600,000 | Added More | 175,000 | 41.17 % | $3,738,000 | $3,822,000 | $84,000 | 2.24 % | $24,500 | | | | | | News Article | History of Apex Capital Llc Ownership Of Halozyme Therapeutics Inc |
| 2009-11-05 | 2009-09-30 | 13F-HR | Parametric Portfolio Associates | Institution | 15,081 | Added More | 1,864 | 14.10 % | $93,955 | $96,066 | $2,111 | 2.24 % | $261 | | | | | | News Article | History of Parametric Portfolio Associates Ownership Of Halozyme Therapeutics Inc |
| 2009-11-05 | 2009-09-30 | 13F-HR | Proshare Advisors Llc | Institution | 17,930 | Sold Some | -6,739 | -27.31 % | $111,704 | $114,214 | $2,510 | 2.24 % | $-943 | | | | | | News Article | History of Proshare Advisors Llc Ownership Of Halozyme Therapeutics Inc |
| 2009-11-02 | 2009-08-31 | N-CSRS | Fidelity Select Portfolios - Technology Portfolio | Science & Tech | 288,890 | No Change | 0 | 0 % | $1,765,118 | $1,840,229 | $75,111 | 4.25 % | $0 | | | | | | News Article | History of Fidelity Select Portfolios - Technology Portfolio Ownership Of Halozyme Therapeutics Inc |
| 2009-10-30 | 2009-08-31 | N-Q | Fidelity Commonwealth Trust - Fidelity Nasdaq Composite Index Tracking Stock | Specialty & Misc | 3,666 | No Compare | | | $22,216 | $23,352 | $1,136 | 5.11 % | | | | | | | News Article | History of Fidelity Commonwealth Trust - Fidelity Nasdaq Composite Index Tracking Stock Ownership Of Halozyme Therapeutics Inc |
| 2009-10-30 | 2009-08-31 | N-CSR | Vanguard World Fund - Vanguard Health Care Index Fund | Health/Biotech | 38,625 | New Holding | 38,625 | 100 % | $234,068 | $246,041 | $11,974 | 5.11 % | $11,974 | | | | | | News Article | History of Vanguard World Fund - Vanguard Health Care Index Fund Ownership Of Halozyme Therapeutics Inc |
| 2009-10-29 | 2009-09-30 | 13F-HR | Dimensional Fund Advisors Inc | Institution | 1,059,188 | Added More | 33,215 | 3.23 % | $6,672,884 | $6,747,028 | $74,143 | 1.11 % | $2,325 | | | | | | News Article | History of Dimensional Fund Advisors Inc Ownership Of Halozyme Therapeutics Inc |
| 2009-10-29 | 2009-08-31 | N-Q | Usaa Mutual Funds Trust - Cornerstone Strategy Fund | Specialty & Misc | 1,000 | Sold Some | -200 | -16.66 % | $6,300 | $6,370 | $70 | 1.11 % | $-14 | | | | | | News Article | History of Usaa Mutual Funds Trust - Cornerstone Strategy Fund Ownership Of Halozyme Therapeutics Inc |
| 2009-10-29 | 2009-08-31 | N-Q | Valic Co I - Small Cap Index Fund | Small-Cap Core | 54,775 | New Holding | 54,775 | 100 % | $345,083 | $348,917 | $3,834 | 1.11 % | $3,834 | | | | | | News Article | History of Valic Co I - Small Cap Index Fund Ownership Of Halozyme Therapeutics Inc |
| 2009-10-28 | 2009-08-31 | N-Q | Brazos Mutual Funds - Brazos Micro Cap Portfolio | Small-Cap Growth | 45,400 | New Holding | 45,400 | 100 % | $283,750 | $289,198 | $5,448 | 1.92 % | $5,448 | | | | | | News Article | History of Brazos Mutual Funds - Brazos Micro Cap Portfolio Ownership Of Halozyme Therapeutics Inc |
| 2009-10-28 | 2009-08-31 | N-Q | Brazos Mutual Funds - Brazos Small Cap Portfolio | Small-Cap Growth | 13,100 | New Holding | 13,100 | 100 % | $81,875 | $83,447 | $1,572 | 1.92 % | $1,572 | | | | | | News Article | History of Brazos Mutual Funds - Brazos Small Cap Portfolio Ownership Of Halozyme Therapeutics Inc |
| 2009-10-27 | 2009-09-30 | 13F-HR | Sterling Johnston Capital Management Lp | Institution | 217,600 | Added More | 37,800 | 21.02 % | $1,475,328 | $1,386,112 | $-89,216 | -6.04 % | $-15,498 | | | | | | News Article | History of Sterling Johnston Capital Management Lp Ownership Of Halozyme Therapeutics Inc |
| 2009-10-26 | 2009-08-31 | N-Q | Tdax Funds Inc - Tdax Independence 2010 Exchange-Traded Fund | Mixed-Asset Target 2010 Funds | | Sold All | -540 | -100 % | | | | -5.62 % | $205 | | | | | | News Article | History of Tdax Funds Inc - Tdax Independence 2010 Exchange-Traded Fund Ownership Of Halozyme Therapeutics Inc |
| 2009-10-26 | 2009-08-31 | N-Q | Tdax Funds Inc - Tdax Independence 2020 Exchange-Traded Fund | Mixed-Asset Target 2020 Funds | | Sold All | -3,360 | -100 % | | | | -5.62 % | $1,277 | | | | | | News Article | History of Tdax Funds Inc - Tdax Independence 2020 Exchange-Traded Fund Ownership Of Halozyme Therapeutics Inc |
| 2009-10-26 | 2009-08-31 | N-Q | Tdax Funds Inc - Tdax Independence 2030 Exchange-Traded Fund | Mixed-Asset Target 2030 Funds | | Sold All | -3,946 | -100 % | | | | -5.62 % | $1,499 | | | | | | News Article | History of Tdax Funds Inc - Tdax Independence 2030 Exchange-Traded Fund Ownership Of Halozyme Therapeutics Inc |
| 2009-10-26 | 2009-08-31 | N-Q | Tdax Funds Inc - Tdax Independence 2040 Exchange-Traded Fund | Mixed-Asset Target 2030+ Funds | | Sold All | -4,305 | -100 % | | | | -5.62 % | $1,636 | | | | | | News Article | History of Tdax Funds Inc - Tdax Independence 2040 Exchange-Traded Fund Ownership Of Halozyme Therapeutics Inc |
| 2009-10-26 | 2009-08-31 | N-Q | Tdax Funds Inc - Tdax Independence In-Target Exchange-Traded Fund | Specialty & Misc | | Sold All | -444 | -100 % | | | | -5.62 % | $169 | | | | | | News Article | History of Tdax Funds Inc - Tdax Independence In-Target Exchange-Traded Fund Ownership Of Halozyme Therapeutics Inc |
| 2009-10-26 | 2009-06-30 | 13F-HR/A | Ameriprise Financial Inc | Institution | 27,600 | No Change | 0 | 0 % | $186,300 | $175,812 | $-10,488 | -5.62 % | $0 | | | | | | News Article | History of Ameriprise Financial Inc Ownership Of Halozyme Therapeutics Inc |
| 2009-10-23 | 2009-09-30 | 13F-HR | Columbus Circle Investors | Institution | 141,137 | Added More | 74,120 | 110.59 % | $987,959 | $899,043 | $-88,916 | -9.00 % | $-46,696 | | | | | | News Article | History of Columbus Circle Investors Ownership Of Halozyme Therapeutics Inc |
| 2009-10-22 | 2009-09-30 | 13F-HR | Blackrock Group Ltd | Institution | 23,700 | Added More | 300 | 1.28 % | $168,507 | $150,969 | $-17,538 | -10.40 % | $-222 | | | | | | News Article | History of Blackrock Group Ltd Ownership Of Halozyme Therapeutics Inc |
| 2009-10-22 | 2009-09-30 | 13F-HR | Blackrock Inc | No Data | | Sold All | -19,423 | -100 % | | | | -10.40 % | $14,373 | | | | | | News Article | History of Blackrock Inc Ownership Of Halozyme Therapeutics Inc |
| 2009-10-22 | 2009-09-30 | 13F-HR | Blackrock Investment Management Llc | Institution | 179,918 | Added More | 35,198 | 24.32 % | $1,279,217 | $1,146,078 | $-133,139 | -10.40 % | $-26,047 | | | | | | News Article | History of Blackrock Investment Management Llc Ownership Of Halozyme Therapeutics Inc |
| 2009-10-21 | 2009-09-30 | 13F-HR | Bank Of New York Mellon Corp | Institution | 282,497 | Sold Some | -40,055 | -12.41 % | $1,980,304 | $1,799,506 | $-180,798 | -9.12 % | $25,635 | | | | | | News Article | History of Bank Of New York Mellon Corp Ownership Of Halozyme Therapeutics Inc |
| 2009-10-21 | 2009-09-30 | 13F-HR/A | Gerry Farber Llc | Institution | 116,000 | No Change | 0 | 0 % | $813,160 | $738,920 | $-74,240 | -9.12 % | $0 | | | | | | News Article | History of Gerry Farber Llc Ownership Of Halozyme Therapeutics Inc |
| 2009-10-21 | 2009-09-30 | 13F-HR | State Board Of Administration Of Florida Retirement System | Institution | 96,274 | Added More | 23,957 | 33.12 % | $674,881 | $613,265 | $-61,615 | -9.12 % | $-15,332 | | | | | | News Article | History of State Board Of Administration Of Florida Retirement System Ownership Of Halozyme Therapeutics Inc |
| 2009-10-20 | 2009-09-30 | 13F-HR | Stoneridge Investment Partners Llc | Institution | | Sold All | -20,500 | -100 % | | | | -11.52 % | $17,015 | | | | | | News Article | History of Stoneridge Investment Partners Llc Ownership Of Halozyme Therapeutics Inc |
| 2009-10-19 | 2009-09-30 | 13F-HR | City National Bank | Institution | 19,225 | Sold Some | -75 | -0.38 % | $149,186 | $122,463 | $-26,723 | -17.91 % | $104 | | | | | | News Article | History of City National Bank Ownership Of Halozyme Therapeutics Inc |
| 2009-10-19 | 2009-09-30 | 13F-HR | Strs Ohio | Institution | 38,800 | Added More | 28,500 | 276.69 % | $301,088 | $247,156 | $-53,932 | -17.91 % | $-39,615 | | | | | | News Article | History of Strs Ohio Ownership Of Halozyme Therapeutics Inc |
| 2009-10-15 | 2009-09-30 | 13F-HR | Public Employees Retirement System Of Ohio | Institution | 76,615 | No Change | 0 | 0 % | $596,065 | $488,038 | $-108,027 | -18.12 % | $0 | | | | | | News Article | History of Public Employees Retirement System Of Ohio Ownership Of Halozyme Therapeutics Inc |
| 2009-10-08 | 2009-09-30 | 13F-HR | Rhumbline Advisers | Institution | 90,835 | Added More | 1,116 | 1.24 % | $655,829 | $578,619 | $-77,210 | -11.77 % | $-949 | | | | | | News Article | History of Rhumbline Advisers Ownership Of Halozyme Therapeutics Inc |
| 2009-10-07 | 2009-07-31 | N-CSR | Fidelity Advisor Series Vii - Fidelity Advisor Biotechnology Fund | Health/Biotech | 25,820 | Added More | 12,910 | 100.00 % | $185,388 | $164,473 | $-20,914 | -11.28 % | $-10,457 | | | | | | News Article | History of Fidelity Advisor Series Vii - Fidelity Advisor Biotechnology Fund Ownership Of Halozyme Therapeutics Inc |
| 2009-10-07 | 2009-07-31 | N-CSR | Profunds - Bull Profund | Large-Cap Core | 4,240 | Added More | 2,100 | 98.13 % | $30,443 | $27,009 | $-3,434 | -11.28 % | $-1,701 | | | | | | News Article | History of Profunds - Bull Profund Ownership Of Halozyme Therapeutics Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Dfa Investment Dimensions Group Inc - International Core Equity Portfolio | International Small-Mid-Cap Value | 76,205 | New Holding | 76,205 | 100 % | $540,293 | $485,426 | $-54,868 | -10.15 % | $-54,868 | | | | | | News Article | History of Dfa Investment Dimensions Group Inc - International Core Equity Portfolio Ownership Of Halozyme Therapeutics Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Dfa Investment Dimensions Group Inc - International Vector Equity Portfolio | No Data | 14,525 | New Holding | 14,525 | 100 % | $102,982 | $92,524 | $-10,458 | -10.15 % | $-10,458 | | | | | | News Article | History of Dfa Investment Dimensions Group Inc - International Vector Equity Portfolio Ownership Of Halozyme Therapeutics Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Dfa Investment Dimensions Group Inc - Us Sustainability Core 1 Portfolio | No Data | 800 | New Holding | 800 | 100 % | $5,672 | $5,096 | $-576 | -10.15 % | $-576 | | | | | | News Article | History of Dfa Investment Dimensions Group Inc - Us Sustainability Core 1 Portfolio Ownership Of Halozyme Therapeutics Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Ishares Trust - Ishares Morningstar Small Growth Index Fund | Small-Cap Growth | 22,954 | New Holding | 22,954 | 100 % | $162,744 | $146,217 | $-16,527 | -10.15 % | $-16,527 | | | | | | News Article | History of Ishares Trust - Ishares Morningstar Small Growth Index Fund Ownership Of Halozyme Therapeutics Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Jnl Investors Series Trust - Jackson Perspective Index 5 Fund | Specialty & Misc | 696 | No Change | 0 | 0 % | $4,935 | $4,434 | $-501 | -10.15 % | $0 | | | | | | News Article | History of Jnl Investors Series Trust - Jackson Perspective Index 5 Fund Ownership Of Halozyme Therapeutics Inc |
| 2009-09-28 | 2009-07-31 | N-Q | Old Westbury Funds Inc - International Fund | International Multi-Cap Core | 10,200 | No Change | 0 | 0 % | $75,684 | $64,974 | $-10,710 | -14.15 % | $0 | | | | | | News Article | History of Old Westbury Funds Inc - International Fund Ownership Of Halozyme Therapeutics Inc |
| 2009-09-28 | 2009-07-31 | N-Q | Powershares Exchange Traded Fund Trust - Powershares Dynamic Small Cap Growth Portfolio | Small-Cap Growth | 1,414 | New Holding | 1,414 | 100 % | $10,492 | $9,007 | $-1,485 | -14.15 % | $-1,485 | | | | | | News Article | History of Powershares Exchange Traded Fund Trust - Powershares Dynamic Small Cap Growth Portfolio Ownership Of Halozyme Therapeutics Inc |
| 2009-09-28 | 2009-07-31 | N-Q | Powershares Exchange-Traded Fund Trust Ii - Powershares Global Biotech Portfolio | No Data | 1,985 | Added More | 271 | 15.81 % | $14,729 | $12,644 | $-2,084 | -14.15 % | $-285 | | | | | | News Article | History of Powershares Exchange-Traded Fund Trust Ii - Powershares Global Biotech Portfolio Ownership Of Halozyme Therapeutics Inc |
| 2009-09-24 | 2009-06-30 | 13F-HR/A | Credit Agricole S A | Institution | 50,000 | No Change | 0 | 0 % | $359,500 | $318,500 | $-41,000 | -11.40 % | $0 | | | | | | News Article | History of Credit Agricole S A Ownership Of Halozyme Therapeutics Inc |
| 2009-09-17 | 2009-07-31 | N-Q | Rydex Etf Trust - Rydex Inverse Russell 2000 Etf | Specialty & Misc | 1,448 | New Holding | 1,448 | 100 % | $10,556 | $9,224 | $-1,332 | -12.62 % | $-1,332 | | | | | | News Article | History of Rydex Etf Trust - Rydex Inverse Russell 2000 Etf Ownership Of Halozyme Therapeutics Inc |
| 2009-09-15 | 2009-06-30 | N-CSRS/A | Wilshire Mutual Funds Inc - Wilshire Small Company Growth Portfolio | Small-Cap Growth | 300 | No Change | 0 | 0 % | $2,214 | $1,911 | $-303 | -13.68 % | $0 | | | | | | News Article | History of Wilshire Mutual Funds Inc - Wilshire Small Company Growth Portfolio Ownership Of Halozyme Therapeutics Inc |
| 2009-09-11 | 2009-06-30 | 13F-HR/A | Barclays Global Investors Uk Holdings Ltd | Institution | 2,823,998 | Added More | 5,142 | 0.18 % | $20,445,746 | $17,988,867 | $-2,456,878 | -12.01 % | $-4,474 | | | | | | News Article | History of Barclays Global Investors Uk Holdings Ltd Ownership Of Halozyme Therapeutics Inc |
| 2009-09-08 | 2009-06-30 | N-CSRS | Jpmorgan Trust Ii - Jpmorgan Technology Fund | Science & Tech | 14 | New Holding | 14 | 100 % | $106 | $89 | $-16 | -15.51 % | $-16 | | | | | | News Article | History of Jpmorgan Trust Ii - Jpmorgan Technology Fund Ownership Of Halozyme Therapeutics Inc |
| 2009-09-08 | 2009-06-30 | N-CSRS | Rydex Series Funds - Banking Fund | Financial Services | 1,676 | Sold Some | -274 | -14.05 % | $12,637 | $10,676 | $-1,961 | -15.51 % | $321 | | | | | | News Article | History of Rydex Series Funds - Banking Fund Ownership Of Halozyme Therapeutics Inc |
| 2009-09-08 | 2009-06-30 | N-CSRS | Rydex Variable Trust - Biotechnology Fund | Health/Biotech | 27,507 | Added More | 27,023 | 5583.26 % | $207,403 | $175,220 | $-32,183 | -15.51 % | $-31,617 | | | | | | News Article | History of Rydex Variable Trust - Biotechnology Fund Ownership Of Halozyme Therapeutics Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Axa Premier Vip Trust - Multimanager Small Cap Growth Portfolio | Small-Cap Growth | 32,200 | Sold Some | -15,400 | -32.35 % | $238,280 | $205,114 | $-33,166 | -13.91 % | $15,862 | | | | | | News Article | History of Axa Premier Vip Trust - Multimanager Small Cap Growth Portfolio Ownership Of Halozyme Therapeutics Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Eq Advisors Trust - Eqalliancebernstein Small Cap Growth Portfolio | Small-Cap Growth | 39,500 | Added More | 10,800 | 37.63 % | $292,300 | $251,615 | $-40,685 | -13.91 % | $-11,124 | | | | | | News Article | History of Eq Advisors Trust - Eqalliancebernstein Small Cap Growth Portfolio Ownership Of Halozyme Therapeutics Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Eq Advisors Trust - Eqalliancebernstein Value Portfolio | Multi-Cap Value | 11,200 | New Holding | 11,200 | 100 % | $82,880 | $71,344 | $-11,536 | -13.91 % | $-11,536 | | | | | | News Article | History of Eq Advisors Trust - Eqalliancebernstein Value Portfolio Ownership Of Halozyme Therapeutics Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Eq Advisors Trust - Eqbond Index Portfolio | Specialty & Misc | 88,914 | Added More | 26,364 | 42.14 % | $657,964 | $566,382 | $-91,581 | -13.91 % | $-27,155 | | | | | | News Article | History of Eq Advisors Trust - Eqbond Index Portfolio Ownership Of Halozyme Therapeutics Inc |
| 2009-09-04 | 2009-06-30 | N-CSR | Jpmorgan Trust I - Jpmorgan Japan Fund | Japanese | | Sold All | -16 | -100 % | | | | -13.91 % | $16 | | | | | | News Article | History of Jpmorgan Trust I - Jpmorgan Japan Fund Ownership Of Halozyme Therapeutics Inc |
| 2009-09-04 | 2009-06-30 | N-CSR | Jpmorgan Trust I - Jpmorgan Prime Money Market Fund | Specialty & Misc | 39 | New Holding | 39 | 100 % | $289 | $248 | $-40 | -13.91 % | $-40 | | | | | | News Article | History of Jpmorgan Trust I - Jpmorgan Prime Money Market Fund Ownership Of Halozyme Therapeutics Inc |
| 2009-09-04 | 2009-06-30 | N-CSR | Jpmorgan Trust I - Jpmorgan Small Cap Core Fund | Small-Cap Core | 88 | Sold Some | -46 | -34.32 % | $651 | $561 | $-91 | -13.91 % | $47 | | | | | | News Article | History of Jpmorgan Trust I - Jpmorgan Small Cap Core Fund Ownership Of Halozyme Therapeutics Inc |
| 2009-09-04 | 2009-06-30 | N-CSR | Jpmorgan Trust Ii - Jpmorgan Core Bond Fund | Multi-Cap Core | 88 | New Holding | 88 | 100 % | $651 | $561 | $-91 | -13.91 % | $-91 | | | | | | News Article | History of Jpmorgan Trust Ii - Jpmorgan Core Bond Fund Ownership Of Halozyme Therapeutics Inc |
| 2009-09-04 | 2009-06-30 | N-CSR | Jpmorgan Trust Ii - Jpmorgan Small Cap Value Fund | Small-Cap Value | 25 | New Holding | 25 | 100 % | $185 | $159 | $-26 | -13.91 % | $-26 | | | | | | News Article | History of Jpmorgan Trust Ii - Jpmorgan Small Cap Value Fund Ownership Of Halozyme Therapeutics Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Profunds - Bull Profund | Large-Cap Core | 2,140 | Sold Some | -3,500 | -62.05 % | $15,836 | $13,632 | $-2,204 | -13.91 % | $3,605 | | | | | | News Article | History of Profunds - Bull Profund Ownership Of Halozyme Therapeutics Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Vanguard Institutional Index Funds - Vanguard Institutional Index Fund | Specialty & Misc | 89,030 | New Holding | 89,030 | 100 % | $658,822 | $567,121 | $-91,701 | -13.91 % | $-91,701 | | | | | | News Article | History of Vanguard Institutional Index Funds - Vanguard Institutional Index Fund Ownership Of Halozyme Therapeutics Inc |
| 2009-09-03 | 2009-06-30 | N-CSRS | Pacific Select Fund - Pd Small-Cap Growth Index Portfolio | No Data | 1,095 | No Compare | | | $7,807 | $6,975 | $-832 | -10.65 % | | | | | | | News Article | History of Pacific Select Fund - Pd Small-Cap Growth Index Portfolio Ownership Of Halozyme Therapeutics Inc |
| 2009-09-03 | 2009-06-30 | N-CSRS | Pacific Select Fund - Small-Cap Index Portfolio | No Data | 33,231 | New Holding | 33,231 | 100 % | $236,937 | $211,681 | $-25,256 | -10.65 % | $-25,256 | | | | | | News Article | History of Pacific Select Fund - Small-Cap Index Portfolio Ownership Of Halozyme Therapeutics Inc |
| 2009-09-03 | 2009-06-30 | N-CSR | Streettracks Series Trust - Spdr Dividend Etf | Specialty & Misc | | Sold All | -11,076 | -100 % | | | | -10.65 % | $8,418 | | | | | | News Article | History of Streettracks Series Trust - Spdr Dividend Etf Ownership Of Halozyme Therapeutics Inc |
| 2009-09-01 | 2009-06-30 | 13F-HR/A | Amvescap Plc | Institution | 2,527 | Sold Some | -2,635 | -51.04 % | $18,169 | $16,097 | $-2,072 | -11.40 % | $2,161 | | | | | | News Article | History of Amvescap Plc Ownership Of Halozyme Therapeutics Inc |
| 2009-09-01 | 2009-06-30 | 13F-HR/A | Fmr Corp | Institution | 301,900 | Added More | 194,700 | 181.62 % | $2,170,661 | $1,923,103 | $-247,558 | -11.40 % | $-159,654 | | | | | | News Article | History of Fmr Corp Ownership Of Halozyme Therapeutics Inc |
| 2009-09-01 | 2009-06-30 | N-CSRS | Rs Investment Trust - Rs Diversified Growth Fund | Multi-Cap Growth | 325,651 | New Holding | 325,651 | 100 % | $2,341,431 | $2,074,397 | $-267,034 | -11.40 % | $-267,034 | | | | | | News Article | History of Rs Investment Trust - Rs Diversified Growth Fund Ownership Of Halozyme Therapeutics Inc |
| 2009-09-01 | 2009-06-30 | N-Q/A | Rydex Series Funds - Biotechnology Fund | Health/Biotech | 175,022 | New Holding | 175,022 | 100 % | $1,258,408 | $1,114,890 | $-143,518 | -11.40 % | $-143,518 | | | | | | News Article | History of Rydex Series Funds - Biotechnology Fund Ownership Of Halozyme Therapeutics Inc |
| 2009-08-31 | 2009-06-30 | N-Q | Northern Lights Fund Trust - Biondo Fund | Health/Biotech | | Sold All | -910 | -100 % | | | | -14.38 % | $974 | | | | | | News Article | History of Northern Lights Fund Trust - Biondo Fund Ownership Of Halozyme Therapeutics Inc |
| 2009-08-31 | 2009-06-30 | N-CSRS | Tiaa Cref Life Fund - Stock Index Fund | Specialty & Misc | 705 | No Change | 0 | 0 % | $5,245 | $4,491 | $-754 | -14.38 % | $0 | | | | | | News Article | History of Tiaa Cref Life Fund - Stock Index Fund Ownership Of Halozyme Therapeutics Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Ishares Trust - Ishares Nasdaq Biotechnology Index Fund | Health/Biotech | 757,550 | Sold Some | -39,928 | -5.00 % | $5,658,899 | $4,825,594 | $-833,305 | -14.72 % | $43,921 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Halozyme Therapeutics Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Ishares Trust - Ishares Russell 2000 Growth Index Fund | Multi-Cap Growth | 444,565 | Added More | 29,573 | 7.12 % | $3,320,901 | $2,831,879 | $-489,022 | -14.72 % | $-32,530 | | | | | | News Article | History of Ishares Trust - Ishares Russell 2000 Growth Index Fund Ownership Of Halozyme Therapeutics Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Ishares Trust - Ishares Russell 2000 Index Fund | Specialty & Misc | 757,145 | Added More | 2,711 | 0.35 % | $5,655,873 | $4,823,014 | $-832,860 | -14.72 % | $-2,982 | | | | | | News Article | History of Ishares Trust - Ishares Russell 2000 Index Fund Ownership Of Halozyme Therapeutics Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Ishares Trust - Ishares Russell 3000 Growth Index Fund | Multi-Cap Growth | 4,177 | Added More | 339 | 8.83 % | $31,202 | $26,607 | $-4,595 | -14.72 % | $-373 | | | | | | News Article | History of Ishares Trust - Ishares Russell 3000 Growth Index Fund Ownership Of Halozyme Therapeutics Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Ishares Trust - Ishares Russell 3000 Index Fund | Specialty & Misc | 17,237 | Added More | 1,020 | 6.28 % | $128,760 | $109,800 | $-18,961 | -14.72 % | $-1,122 | | | | | | News Article | History of Ishares Trust - Ishares Russell 3000 Index Fund Ownership Of Halozyme Therapeutics Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Ishares Trust - Ishares Russell Microcap Index Fund | Specialty & Misc | | Sold All | -70,207 | -100 % | | | | -14.72 % | $77,228 | | | | | | News Article | History of Ishares Trust - Ishares Russell Microcap Index Fund Ownership Of Halozyme Therapeutics Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Riversource Strategy Series Inc - Riversource Small Cap Growth Fund | Small-Cap Growth | 27,600 | New Holding | 27,600 | 100 % | $206,172 | $175,812 | $-30,360 | -14.72 % | $-30,360 | | | | | | News Article | History of Riversource Strategy Series Inc - Riversource Small Cap Growth Fund Ownership Of Halozyme Therapeutics Inc |
| 2009-08-28 | 2009-06-30 | 13F-HR/A | Wells Fargo And Co | Institution | 22,100 | Added More | 6,500 | 41.66 % | $165,087 | $140,777 | $-24,310 | -14.72 % | $-7,150 | | | | | | News Article | History of Wells Fargo And Co Ownership Of Halozyme Therapeutics Inc |
| 2009-08-27 | 2009-06-30 | N-Q | Leuthold Funds Inc - Leuthold Core Investment Fund | Flexible Portfolio | 235,896 | Sold Some | -178 | -0.07 % | $1,809,322 | $1,502,658 | $-306,665 | -16.94 % | $231 | | | | | | News Article | History of Leuthold Funds Inc - Leuthold Core Investment Fund Ownership Of Halozyme Therapeutics Inc |
| 2009-08-27 | 2009-06-30 | N-Q | Leuthold Funds Inc - Leuthold Select Industries Fund | Specialty Dvsfd Eq | 14,341 | Added More | 576 | 4.18 % | $109,995 | $91,352 | $-18,643 | -16.94 % | $-749 | | | | | | News Article | History of Leuthold Funds Inc - Leuthold Select Industries Fund Ownership Of Halozyme Therapeutics Inc |
| 2009-08-27 | 2009-06-30 | N-Q | Old Mutual Advisor Funds Ii - Old Mutual Strategic Small Company Fund | Small-Cap Core | 59,288 | New Holding | 59,288 | 100 % | $454,739 | $377,665 | $-77,074 | -16.94 % | $-77,074 | | | | | | News Article | History of Old Mutual Advisor Funds Ii - Old Mutual Strategic Small Company Fund Ownership Of Halozyme Therapeutics Inc |
| 2009-08-27 | 2009-06-30 | N-Q | Tiaa Cref Institutional Mutual Funds - Equity Index Fund | Specialty & Misc | 42,454 | Added More | 27,461 | 183.15 % | $325,622 | $270,432 | $-55,190 | -16.94 % | $-35,699 | | | | | | News Article | History of Tiaa Cref Institutional Mutual Funds - Equity Index Fund Ownership Of Halozyme Therapeutics Inc |
| 2009-08-27 | 2009-06-30 | N-Q | Tiaa Cref Institutional Mutual Funds - Growth Equity Fund | Multi-Cap Growth | 278,669 | Added More | 257,308 | 1204.56 % | $2,137,391 | $1,775,122 | $-362,270 | -16.94 % | $-334,500 | | | | | | News Article | History of Tiaa Cref Institutional Mutual Funds - Growth Equity Fund Ownership Of Halozyme Therapeutics Inc |
| 2009-08-27 | 2009-06-30 | N-CSRS | Vanguard Index Funds - Vanguard Extended Market Index Fund | Mid-Cap Core | 384,017 | New Holding | 384,017 | 100 % | $2,945,410 | $2,446,188 | $-499,222 | -16.94 % | $-499,222 | | | | | | News Article | History of Vanguard Index Funds - Vanguard Extended Market Index Fund Ownership Of Halozyme Therapeutics Inc |
| 2009-08-27 | 2009-06-30 | N-CSRS | Vanguard Index Funds - Vanguard Growth Index Fund | Large-Cap Growth | 655,306 | New Holding | 655,306 | 100 % | $5,026,197 | $4,174,299 | $-851,898 | -16.94 % | $-851,898 | | | | | | News Article | History of Vanguard Index Funds - Vanguard Growth Index Fund Ownership Of Halozyme Therapeutics Inc |
| 2009-08-27 | 2009-06-30 | N-CSRS | Vanguard Index Funds - Vanguard Total Stock Market Index Fund | Multi-Cap Core | 782,543 | New Holding | 782,543 | 100 % | $6,002,105 | $4,984,799 | $-1,017,306 | -16.94 % | $-1,017,306 | | | | | | News Article | History of Vanguard Index Funds - Vanguard Total Stock Market Index Fund Ownership Of Halozyme Therapeutics Inc |
| 2009-08-27 | 2008-06-30 | N-CSRS | Vanguard Balanced Index Funds - Vanguard Balanced Index Fund | Mixed-Asset Target Allocation Growth | 33,600 | No Change | 0 | 0 % | $257,712 | $214,032 | $-43,680 | -16.94 % | $0 | | | | | | News Article | History of Vanguard Balanced Index Funds - Vanguard Balanced Index Fund Ownership Of Halozyme Therapeutics Inc |
| 2009-08-27 | 2008-06-30 | N-CSRS | Vanguard Balanced Index Funds - Vanguard Balanced Index Fund | Mixed-Asset Target Allocation Growth | 43,100 | Added More | 9,500 | 28.27 % | $330,577 | $274,547 | $-56,030 | -16.94 % | $-12,350 | | | | | | News Article | History of Vanguard Balanced Index Funds - Vanguard Balanced Index Fund Ownership Of Halozyme Therapeutics Inc |
| 2009-08-25 | 2009-06-30 | N-Q | Nicholas Applegate Institutional Funds - International Growth Fund | Multi-Cap Growth | | Sold All | -35,900 | -100 % | | | | -15.85 % | $43,080 | | | | | | News Article | History of Nicholas Applegate Institutional Funds - International Growth Fund Ownership Of Halozyme Therapeutics Inc |
| 2009-08-20 | 2009-06-30 | 13F-HR/A | Driehaus Capital Management Llc | Institution | 148,465 | New Holding | 148,465 | 100 % | $1,137,242 | $945,722 | $-191,520 | -16.84 % | $-191,520 | | | | | | News Article | History of Driehaus Capital Management Llc Ownership Of Halozyme Therapeutics Inc |
RSS feed for HALO